Shu-ying Wu

A Multifunctional Drug Combination Shows Highly Potent Therapeutic Efficacy against Human Cancer Xenografts in Athymic Mice

Y. Zhen, Yi Li, Xiujun Liu, 2014, PloS one.

Detection of homozygous deletions and mutations in the CDKN2A gene in hydatidiform moles

Xiaowei Zhang, Shu-ying Wu, Jing Wang, 2008 .

A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity.

Y. Zhen, Qing-fang Miao, B. Shang, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Synergy of gemcitabine and lidamycin associated with NF-κB downregulation in pancreatic carcinoma cells

J. Chen, Y. Zhen, Shu-ying Wu, 2008, Acta Pharmacologica Sinica.

Distribution of the alleles at loci D16S539, D7S820, and D13S317 in hydatidiform mole genome from Chinese women and its relationship with clinical prognosis.

Rong Li, Hong-yan Guo, Xiu-yun Wang, 2006, Cancer genetics and cytogenetics.

[A random control study of indomethacin-containing MYCu intrauterine contraceptive device for 60 months].

Yan-hui Zhao, Shu-ying Wu, Li-yan Wang, 2013, Zhonghua yi xue za zhi.

[Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial].

Jian Li, C. Xiong, Zi-rong Huang, 2009, Zhonghua fu chan ke za zhi.

Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.

Y. Zhen, B. Shang, Shu-ying Wu, 2011, Cancer letters.

A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity

Y. Zhen, B. Shang, Yi Li, 2016, Scientific Reports.

Inhibitory effects of emodin on angiogenesis.

Y. Zhen, Xin-hua Wang, Shu-ying Wu, 2004, Yao xue xue bao = Acta pharmaceutica Sinica.